Vitamin A vs placebo
- Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 116 participantsVery low
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Vitamin A supplementation (200,000 to 400,000 IU) showed no clear difference in maternal mortality compared with placebo or no treatment (moderate certainty).
Vitamin A supplementation (200,000 to 400,000 IU) showed no clear difference in maternal adverse effects after administration: abdominal pain compared with placebo or no treatment (low certainty).
Vitamin A supplementation (200,000 to 400,000 IU) showed no clear difference in infant mortality compared with placebo or no treatment (low certainty).
It is very uncertain whether vitamin A supplementation (200,000 to 400,000 IU) changes infant morbidity (gastroenteritis) compared with placebo or no treatment (very low certainty).
Vitamin A supplementation (200,000 to 400,000 IU) showed no clear difference in infant adverse effects: bulging fontanelle compared with placebo or no treatment (low certainty).
Vitamin E (capsules 2000 IU/day in two divided doses) showed no clear difference in adverse events Number of participants reporting ≥ 1 serious adverse… compared with placebo (moderate certainty).
Vitamin E (capsules 2000 IU/day in two divided doses) showed no clear difference in deaths Number of deaths compared with placebo (moderate certainty).
Vitamin E (capsules 2000 IU/day in two divided doses) showed no clear difference in progression to Alzheimer's disease Number of people progressing to AD compared with placebo (moderate certainty).
The review found no eligible studies for this question.
Vitamin E (capsules 2000 IU/day in two divided doses) showed no clear difference in death Number of deaths over 36 months compared with placebo (moderate certainty).